| C09CA01 |
Losartan |
Lozap 50 |
Film coated tablet |
50 |
mg |
30 |
Zentiva a.s., Словакия |
50 |
mg |
- |
3.52 |
0.11339 |
3.4 |
25% |
0.85 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-2674/20.03.2013 г. |
02.04.2016 |
08.09.2012 |
|
Активен |
1389 |
| C09CA01 |
Losartan |
RASOLTAN |
Film coated tablet |
50 |
mg |
30 |
Актавис EАД, България |
50 |
mg |
- |
7.09 |
0.11339 |
3.4 |
25% |
0.85 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-3552/16.05.2014.; НСР-6775/23.07.2015; НСР-14272/26.10.2017 |
02.12.2017 |
|
|
Активен |
2811 |
| C09CA01 |
Losartan |
RASOLTAN |
Film coated tablet |
50 |
mg |
30 |
Актавис EАД, България |
50 |
mg |
- |
7.39 |
0.11733 |
3.52 |
25% |
0.88 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 92/23.06.2010; КЦРР-710/05.06.2012 г.; НСР-1225/23.09.2013; КЦРР-2652/20.03.2013 и КП-248/12.11.2013; НСР-3553/16.05.2014 |
02.06.2014 |
|
|
Заличен |
2811 |
| C09CA01 |
Losartan |
Zatan |
Film coated tablet |
50 |
mg |
30 |
Софарма АД, България |
50 |
mg |
- |
3.52 |
0.11733 |
3.52 |
25% |
0.88 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-2910/05.03.2014; HCP-5715/26.02.2015. |
16.03.2015 |
|
|
Заличен |
2600 |
| C09CA01 |
Losartan |
Zatan |
Film coated tablet |
50 |
mg |
30 |
Софарма АД, България |
50 |
mg |
- |
3.52 |
0.11733 |
3.52 |
25% |
0.88 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-1578/05.11.2012 г; НСР-2044/11.12.2013 |
16.01.2014 |
|
|
Заличен |
2600 |
| C09CA01 |
Losartan 100% |
C09CA01 Losartan 100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09CA01 |
Losartan |
LORISTA |
Film coated tablet |
100 |
mg |
28 |
KRKA, d.d., Словения |
50 |
mg |
5.35 |
- |
0.09554 |
5.35 |
100% |
5.35 |
|
I10 |
HCP-8874/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
1497 |
| C09CA01 |
Losartan |
LORISTA |
Film coated tablet |
50 |
mg |
28 |
KRKA, d.d., Словения |
50 |
mg |
3.47 |
- |
0.09554 |
2.68 |
100% |
2.68 |
|
I10 |
HCP-8872/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
1285 |
| C09CA01 |
Losartan |
Losartan Potassium Aurobindo |
Film coated tablet |
50 |
mg |
28 |
Aurobindo Pharma (Malta) Limited, Малта |
50 |
mg |
6.71 |
- |
0.09554 |
2.68 |
100% |
2.68 |
|
I10 |
HCP-8877/13.04.2016; НСР-13417/04.08.2017; НСР-19098/27.06.2019 |
02.08.2019 |
|
|
Заличен |
3929 |
| C09CA01 |
Losartan |
Lotar |
Film coated tablet |
100 |
mg |
30 |
Alkaloid – INT d.o.o., Словения |
50 |
mg |
10.51 |
- |
0.09554 |
5.73 |
100% |
5.73 |
|
I10 |
HCP-8875/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
3827 |
| C09CA01 |
Losartan |
Lozap 50 |
Film coated tablet |
50 |
mg |
30 |
Zentiva a.s., Словакия |
50 |
mg |
2.96 |
- |
0.09554 |
2.87 |
100% |
2.87 |
|
I10 |
HCP-8873/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
1389 |
| C09CA01 |
Losartan |
RASOLTAN |
Film coated tablet |
50 |
mg |
30 |
Актавис EАД, България |
50 |
mg |
5.98 |
- |
0.09554 |
2.87 |
100% |
2.87 |
|
I10 |
HCP-8876/13.04.2016.; НСР-14272/26.10.2017. |
02.08.2019 |
|
|
Активен |
2811 |
| C09CA02 |
Eprosartan |
C09CA02 Eprosartan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09CA02 |
Eprosartan |
Teveten |
Film coated tablet |
600 |
mg |
28 |
Майлан ЕООД, България |
600 |
mg |
- |
26.6 |
0.95 |
26.6 |
25% |
6.65 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№40/27.08.2009; КЦРР-493/19.04.2012 г.; КЦРР-1427/25.09..2012 г.; НСР-959/12.08.2013; НСР-4531/22.08.2014; КП-110/20.09.2016 и НСР-9408/01.06.2016; НСР-15769/25.05.2018 |
02.07.2018 |
08.09.2012 |
|
Активен |
2056 |
| C09CA02 |
Eprosartan 100% |
C09CA02 Eprosartan 100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09CA02 |
Eprosartan |
Teveten |
Film coated tablet |
600 |
mg |
28 |
Майлан ЕООД, България |
600 |
mg |
22.74 |
- |
0.81214 |
22.74 |
100% |
22.74 |
|
I10 |
HCP-8878/13.04.2016; КП-110/20.09.2016 и НСР-9408/01.06.2016; НСР-15769/25.05.2018. |
02.08.2019 |
08.09.2012 |
|
Активен |
2056 |
| C09CA03 |
Valsartan |
C09CA03 Valsartan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09CA03 |
Valsartan |
Diovan |
Film coated tablet |
160 |
mg |
28 |
Novartis Pharma GmbH, Германия |
80 |
mg |
- |
14.16 |
0.1255 |
7.03 |
25% |
1.76 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
№ 79/10.05.2010; КЦРР-673/30.05.2012 г.; КЦРР-2502/06.03.2013 г; НСР-2140/14.12.2013; НСР-4327/05.08.2014; НСР-10742/27.10.2016; НСР-14820/18.01.2018 |
02.03.2018 |
08.09.2012 |
|
Активен |
3087 |
| C09CA03 |
Valsartan |
Nortivan |
Film coated tablet |
160 |
mg |
28 |
Gedeon Richter Plc., Унгария |
80 |
mg |
- |
7.61 |
0.09464 |
5.3 |
25% |
1.32 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
№ 66/ 08.04.2010; № 79/10.05.2010; № 84/27.05.2010; HCР-278/28.06.2013;НСР-1200/13.09.2013; НСР-5462/16.01.2015.; НСР-3813/16.06.2014. и КП-86/06.04.2015; НСР-8270/26.02.2016 |
02.04.2016 |
08.09.2012 |
|
Заличен |
3803 |
| C09CA03 |
Valsartan |
Nortivan |
Film coated tablet |
80 |
mg |
28 |
Gedeon Richter Plc., Унгария |
80 |
mg |
- |
2.65 |
0.09464 |
2.65 |
25% |
0.66 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
№ 66/ 08.04.2010; № 79/10.05.2010; № 84/27.05.2010; HCР-279/28.06.2013; НСР-1198/13.09.2013; НСР-5463/16.01.2015; НСР-3813/16.06.2014. и КП-86/06.04.2015; НСР-8406/07.03.2016 |
02.04.2016 |
08.09.2012 |
|
Заличен |
3802 |
| C09CA03 |
Valsartan |
Nortivan Neo |
Film coated tablet |
160 |
mg |
28 |
Gedeon Richter Plc., Унгария |
80 |
mg |
- |
9.78 |
0.1255 |
7.03 |
25% |
1.76 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
НСР-7274/21.10.2015.; НСР-14900/25.01.2018; НСР-18250/22.03.2019 |
02.05.2019 |
|
|
Заличен |
4089 |
| C09CA03 |
Valsartan |
Nortivan Neo |
Film coated tablet |
80 |
mg |
28 |
Gedeon Richter Plc., Унгария |
80 |
mg |
- |
4.88 |
0.1255 |
3.51 |
25% |
0.88 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
НСР-7274/21.10.2015.; НСР-14899/25.01.2018; НСР-18248/22.03.2019 |
02.05.2019 |
|
|
Заличен |
4088 |
| C09CA03 |
Valsartan |
Sarteg |
Film coated tablet |
160 |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
80 |
mg |
- |
9.42 |
0.1255 |
7.53 |
25% |
1.88 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
НСР-6199/15.05.2015.; НСР-16332/02.08.2018; НСР-18653/03.05.2019 |
02.06.2019 |
|
|
Заличен |
3852 |
| C09CA03 |
Valsartan |
Sarteg |
Film coated tablet |
160 |
mg |
28 |
EGIS Pharmaceuticals PLC, Унгария |
80 |
mg |
- |
7.61 |
0.09464 |
5.3 |
25% |
1.32 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
НСР-4580/12.09.2014; НСР-6275/22.05.2015 (допуска предварително изпълнение) |
02.06.2015 |
|
|
Заличен |
3157 |
| C09CA03 |
Valsartan |
Sarteg |
Film coated tablet |
160 |
mg |
28 |
EGIS Pharmaceuticals PLC, Унгария |
80 |
mg |
- |
7.61 |
0.10214 |
5.72 |
25% |
1.43 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
№ 34/21,08,2009; № 79/10.05.2010; НСР-896/09.08.2013 и КП-14/05.03.2014; НСР-4464/15.08.2014 |
16.09.2014 |
|
|
Заличен |
3157 |